Charcot-Marie-Tooth disease type 2 caused by mutation in NEFL is a rare inherited nerve disease where damage happens mainly to the axons (the long “wires”) of the peripheral nerves that control movement and feeling in the feet, legs, hands, and arms. It is often called NEFL-related Charcot-Marie-Tooth disease and is usually passed down in an autosomal dominant pattern, which means one changed copy of the NEFL gene from either parent is enough to cause the disease. NCBI+2National Organization for Rare Disorders+2
Charcot-Marie-Tooth disease type 2 caused by a mutation in the NEFL gene (often called CMT2E/1F or NEFL-related CMT) is a rare, inherited nerve disease. It mainly damages the long nerves in the arms and legs (peripheral nerves). These nerves slowly lose their function, so the muscles they control become weak and thin, and feeling in the feet and hands is reduced. ScienceDirect+1
The NEFL gene gives instructions to make neurofilament light chain, a structural protein inside nerve cells. When NEFL is mutated, the nerve fibers become fragile and cannot carry electrical signals properly. This usually causes slowly progressive weakness in the feet, lower legs, hands, and sometimes problems with walking balance from childhood or early adult life. There is no cure yet, but many supportive treatments can improve quality of life and delay complications. ScienceDirect+2Wiley Online Library+2
The NEFL gene gives instructions to make neurofilament light chain, a key structural protein inside nerve cells that helps keep the long axons strong and open for signal flow. When NEFL is changed by a mutation, the neurofilament proteins can misfold or clump, the axon becomes unstable, and nerve signals slow down or fail to reach the muscles and skin. Over time this causes slowly progressive weakness, muscle wasting, foot deformities, balance problems, and reduced feeling in the feet and hands. PMC+2American Academy of Neurology+2
NEFL-related CMT can appear from early childhood to adulthood. Many people notice first symptoms as clumsiness, frequent falls, or difficulty running, and later they develop thin lower legs, high arches, and hand weakness. Some NEFL mutations can also cause additional signs like tremor, pyramidal signs (stiff reflexes), or ataxia (poor coordination), so the condition can look different from person to person even within the same family. PMC+2JCN+2
Other names
This condition is known in medical books by several different names, which can be confusing but all point to the same basic disease group:
Charcot-Marie-Tooth disease type 2E (CMT2E) – the usual name when the nerve damage is mainly axonal. National Organization for Rare Disorders+1
Charcot-Marie-Tooth disease type 1F (CMT1F) – used when the same NEFL mutations mainly cause demyelinating neuropathy, where the myelin sheath is more affected. JCN+1
NEFL-related Charcot-Marie-Tooth disease – a general term used in genetics and neurology clinics. PMC+1
NEFL-related hereditary motor and sensory neuropathy (NEFL-HMSN) – another medical phrase that highlights both motor and sensory nerve involvement. NCBI+1
NEFL-related axonal neuropathy or NEFL-related sensorimotor neuropathy – descriptive terms showing that NEFL mutations cause damage to the long motor and sensory axons. PMC+1
In very severe early-onset forms, some patients can show a Dejerine–Sottas–like phenotype, a term used for very early, severe hereditary neuropathy. JCN+1
Types
NEFL-related Charcot-Marie-Tooth disease does not have many completely separate “types,” but doctors divide it into patterns based on nerve conduction studies and severity. These patterns help guide diagnosis and counseling: PMC+2Wiley Online Library+2
Axonal CMT (CMT2E) – the main form, where nerve conduction velocities are relatively preserved but amplitudes (signal size) are reduced, showing loss of axons; weakness and wasting are prominent in feet and hands. PMC+2National Organization for Rare Disorders+2
Demyelinating CMT (CMT1F) – in some families, NEFL mutations mostly damage myelin, giving very slow nerve conduction velocities and thicker myelin “onion bulb” changes on nerve biopsy. Nature+2Wiley Online Library+2
Intermediate NEFL-related CMT – many patients have conduction velocities between classical demyelinating and axonal ranges, so doctors call this an “intermediate” neuropathy. Wiley Online Library+1
Early-onset severe NEFL neuropathy – some NEFL variants cause symptoms in infancy or early childhood with severe weakness, delayed motor milestones, and sometimes a Dejerine–Sottas–like picture. JCN+2PMC+2
Recessive NEFL-related neuropathy – rare families have two altered NEFL copies (one from each parent) leading to a severe early-onset axonal neuropathy. Muscular Dystrophy Association+1
Causes and disease mechanisms
In reality, the main cause of this disease is always a pathogenic mutation in the NEFL gene. However, researchers describe many detailed genetic and biological factors that act as “sub-causes” or mechanisms, and together they explain how and why nerve damage happens. PMC+2American Academy of Neurology+2
Pathogenic NEFL point mutations – small changes in the DNA code (such as E90K, N98S, P22 mutations, E397K, and others) alter the amino acid sequence of the neurofilament light chain and start the disease process. PMC+2Nature+2
Disrupted neurofilament assembly – mutant NEFL protein cannot properly assemble with other neurofilament subunits, so the internal “skeleton” of the axon becomes unstable and fragile. PMC+2American Academy of Neurology+2
Protein misfolding and aggregation – abnormal NEFL molecules may fold in the wrong way and clump inside neurons, blocking normal cell transport and stressing the cell. PMC+2American Academy of Neurology+2
Axonal transport failure – neurofilaments help keep axons open so nutrients and signals can move; when NEFL is defective, transport of organelles and molecules along the long axon is slowed or blocked, leading to degeneration from the tips upward. PMC+2ScienceDirect+2
Loss of large-myelinated fibers – biopsies show a uniform loss of large myelinated nerve fibers in NEFL-related neuropathy, which explains the marked weakness and loss of vibration and position sense. PMC+2repositoriosaludmadrid.es+2
Secondary myelin changes – although NEFL mutations directly affect axons, the myelin sheath can become thin, irregular, or show “onion bulb” formations as Schwann cells try to repair damaged axons. PMC+2Nature+2
Dominant-negative effect – in autosomal dominant families, the mutant NEFL protein can interfere with the function of the normal protein from the healthy gene copy, worsening the impact of the mutation. PMC+2American Academy of Neurology+2
Haploinsufficiency or loss-of-function – some NEFL variants may reduce the total amount of working neurofilament light chain, so the axon does not have enough structural support. PMC+2American Academy of Neurology+2
Mitochondrial stress and energy failure – disturbed axonal structure and transport can damage mitochondrial function in long peripheral axons, making them more sensitive to energy shortage and further axon loss. ScienceDirect+2American Academy of Neurology+2
Abnormal phosphorylation sites – mutations near important phosphorylation motifs (such as Pro22 region) may disturb how NEFL is regulated by kinases, altering axonal stability and leading to neuropathy. Nature+2PMC+2
Early developmental nerve damage – in severe NEFL mutations, axons can be abnormal from infancy, leading to delayed walking, hypotonia, or early deformities, which shows that development itself is disturbed. PMC+2JCN+2
Progressive axonal degeneration with age – even in milder NEFL mutations, axons slowly degenerate over years, so weakness and sensory loss gradually worsen with aging. PMC+2MalaCards+2
Length-dependent vulnerability – the longest nerves to the feet and legs are affected first, so symptoms start distally and move upward; this “length-dependent” pattern is typical of CMT2E. NCBI+2Cleveland Clinic+2
Genetic background and modifier genes – other genes involved in nerve health can modify how strongly a NEFL mutation shows itself, explaining why severity and age of onset vary within and between families. American Academy of Neurology+2PFM Journal+2
De novo NEFL mutations – sometimes the mutation appears new in the patient and is not present in either parent; this still directly causes the disease but changes the family inheritance pattern. PMC+2American Academy of Neurology+2
Recessive NEFL mutations – in rare cases, two loss-of-function NEFL variants (one from each parent) act together and cause a severe, early-onset neuropathy. Muscular Dystrophy Association+2PMC+2
Cumulative micro-trauma to nerves – because NEFL-mutant axons are fragile, normal life stresses like minor injuries or repetitive movements may contribute to more rapid axonal loss over many years. ScienceDirect+2PMC+2
Coexisting acquired neuropathy – if a person with NEFL mutation also develops diabetes, vitamin deficiency, or toxin exposure, the acquired neuropathy adds to genetic damage, making symptoms worse; here NEFL change is the primary cause and other factors are additional contributors. Hospital for Special Surgery+2PMC+2
Central nervous system involvement in some variants – some NEFL mutations also affect brain pathways (pyramidal tracts, cerebellar circuits), leading to spasticity or ataxia, which adds to disability. PMC+2Wiley Online Library+2
Chronic neuroinflammation and glial response – ongoing axonal degeneration can trigger local inflammatory and glial responses around nerves, which may further damage axons and myelin over time. ScienceDirect+2PMC+2
Symptoms
The symptoms of NEFL-related CMT are similar to other CMT2 forms but may show extra features like tremor or pyramidal signs in some patients. Symptoms usually get worse slowly over many years. PMC+2NCBI+2
Distal leg weakness – the earliest and most common problem is weakness in the muscles that lift the foot and toes, making it hard to run, climb stairs, or walk on heels. Mayo Clinic+2Cleveland Clinic+2
Foot drop and tripping – because ankle dorsiflexion is weak, the front of the foot may drag, causing frequent tripping, stubbed toes, or a “steppage” gait where the person lifts the knee high to clear the foot. Mayo Clinic+2Cleveland Clinic+2
Muscle wasting in lower legs – over time, calf muscles become thin and the legs can look like an “inverted champagne bottle,” with narrow calves and relatively normal thighs. Mayo Clinic+2Cleveland Clinic+2
High foot arches (pes cavus) – structural changes in the feet, such as very high arches and hammertoes, are common and can cause pain, calluses, and difficulty finding comfortable shoes. Mayo Clinic+2Cleveland Clinic+2
Hand weakness and fine-motor problems – as the disease progresses, small muscles in the hands weaken, making tasks like buttoning, writing, using small tools, or opening jars difficult. Cleveland Clinic+2NCBI+2
Loss of vibration and position sense – many patients lose deep sensory input in feet and sometimes hands, so they may not feel vibration, and they may have trouble knowing where their toes are without looking. NCBI+2Cleveland Clinic+2
Numbness and tingling – reduced or changed sensation, often starting as numbness, pins-and-needles, or burning in toes and soles, then moving upward with time. Mayo Clinic+2Cleveland Clinic+2
Poor balance and unsteady walking – because of weakness and sensory loss, balance is affected, especially in the dark or on uneven ground, and falls become more likely. Cleveland Clinic+2@Medanta+2
Reduced or absent tendon reflexes – ankle and knee reflexes are often reduced or absent on neurological examination, reflecting damage to the peripheral reflex arcs. PMC+2National Organization for Rare Disorders+2
Postural tremor – some NEFL mutations cause a fine shaking of the hands when they are held out or when trying to do a task, called postural or action tremor. NCBI+2PMC+2
Pyramidal signs or spasticity in some patients – in a subset of NEFL-related CMT, examination shows brisk reflexes, Babinski sign, or mild stiffness, suggesting involvement of central motor pathways as well as peripheral nerves. PMC+2Wiley Online Library+2
Ataxia and coordination problems – some people have difficulty with coordination, especially with tandem walking (heel-to-toe), reaching, or fine leg movements, partly from sensory loss and sometimes from cerebellar involvement. PMC+2Wiley Online Library+2
Hearing loss in a minority of cases – sensorineural hearing loss has been reported in some NEFL-mutated families, reflecting broader involvement of sensory pathways. NCBI+2PMC+2
Fatigue and effort intolerance – chronic muscle weakness and the extra energy needed to walk with abnormal gait often lead to tiredness and reduced endurance in daily activities. Cleveland Clinic+2@Medanta+2
Pain or discomfort in feet and legs – some patients experience neuropathic pain, cramps, or aching in muscles and joints due to abnormal biomechanics and nerve damage, though pain severity varies widely. Mayo Clinic+2Cleveland Clinic+2
Diagnostic tests
Physical examination tests
1. Comprehensive neurological examination – the neurologist checks muscle strength in feet, legs, hands, and arms; looks for muscle wasting; tests reflexes; and assesses sensation (touch, pinprick, vibration, joint position) to confirm a chronic length-dependent sensorimotor neuropathy pattern. NCBI+2PMC+2
2. Gait and balance assessment – watching the way the person walks helps identify a steppage gait, foot drop, wide-based stance, or ataxic features; balance is tested with normal walking, heel and toe walking, and tandem walking. Cleveland Clinic+2@Medanta+2
3. Foot and skeletal deformity evaluation – inspection of the feet, ankles, knees, and spine looks for pes cavus, hammertoes, claw toes, ankle instability, scoliosis, or other deformities that commonly develop in CMT. Mayo Clinic+2Cleveland Clinic+2
4. Family history and pedigree analysis (clinical step) – carefully mapping affected and unaffected family members over generations helps support autosomal dominant inheritance and suggests a genetic neuropathy such as NEFL-related CMT. NCBI+2Hospital for Special Surgery+2
Manual bedside tests
5. Manual muscle testing (MMT) – the clinician grades the strength of key muscle groups (ankle dorsiflexors, plantar flexors, evertors, intrinsic hand muscles) by pushing against the patient’s efforts, which documents the pattern and severity of weakness over time. Cleveland Clinic+2Orthobullets+2
6. Heel-walk, toe-walk, and squat tests – simple functional tasks like walking on heels, walking on toes, and rising from a squat without using the hands help show subtle distal weakness and balance issues typical of CMT. Cleveland Clinic+2@Medanta+2
7. Romberg and sensory balance tests – standing with feet together and then closing the eyes (Romberg test) checks whether loss of position sense in the feet leads to increased swaying or falling, which suggests sensory neuropathy. PMC+2Cleveland Clinic+2
8. Joint range-of-motion and contracture assessment – manual movement of ankles, knees, and toes tests for stiffness, contractures, or tight Achilles tendons, which guide decisions about physiotherapy, braces, or surgery. Hospital for Special Surgery+2Cleveland Clinic+2
Laboratory and pathological tests
9. Basic blood tests to exclude acquired causes – tests such as complete blood count, metabolic panel, fasting glucose, HbA1c, vitamin B12, folate, thyroid function, and serum protein electrophoresis are often done to rule out acquired neuropathies like diabetes, vitamin deficiency, or paraproteinemia before focusing on inherited CMT. PMC+2Hospital for Special Surgery+2
10. Nerve-specific antibody and autoimmune panels when needed – in unclear cases, doctors may check for autoimmune neuropathies with tests like ANA or anti-myelin antibodies to separate NEFL-related CMT from treatable inflammatory neuropathies. PMC+2ARUP Consult+2
11. Targeted NEFL gene sequencing – once an inherited neuropathy is suspected, genetic testing can directly sequence the NEFL gene to look for known or novel pathogenic variants that confirm NEFL-related CMT. PMC+2Mayo Clinic Laboratories+2
12. Next-generation hereditary neuropathy gene panel – many centers use a large NGS panel that includes NEFL along with dozens of other CMT-related genes, increasing the chance of finding the exact genetic cause in one test. Mayo Clinic Laboratories+2ARUP Consult+2
13. Segregation analysis in family members – after finding a NEFL variant, testing parents, siblings, or children helps show whether the variant tracks with disease in the family, strengthening the evidence that this variant causes the neuropathy. PMC+2American Academy of Neurology+2
14. Sural nerve biopsy (rarely needed) – in difficult cases, a small sensory nerve sample from the leg may be taken to examine under a microscope; NEFL-related neuropathy typically shows loss of large myelinated fibers and sometimes onion bulb formations and thin myelin. PMC+2repositoriosaludmadrid.es+2
Electrodiagnostic tests
15. Motor nerve conduction studies (NCS) – electrodes stimulate peripheral nerves and record muscle responses, measuring conduction velocity and amplitude; NEFL-related CMT may show a broad range, but CMT2E usually has relatively preserved velocities with low amplitudes, consistent with axonal loss. PMC+2Wiley Online Library+2
16. Sensory nerve conduction studies – similar tests on sensory nerves detect reduced or absent sensory action potentials, confirming sensory axon involvement and helping distinguish axonal from demyelinating patterns. PMC+2Muscular Dystrophy Association+2
17. Electromyography (EMG) – a fine needle in selected muscles records electrical activity, showing chronic denervation and re-innervation changes that match a length-dependent motor neuropathy and help rule out primary muscle disease. Muscular Dystrophy Association+2PMC+2
Imaging tests
18. Foot and ankle X-rays – simple radiographs can show fixed deformities such as high arches, hammertoes, and joint misalignment; this helps orthopaedic and rehabilitation teams plan braces or corrective surgery. Hospital for Special Surgery+2NCBI+2
19. MRI of brain and spinal cord when central signs appear – if the patient has pyramidal signs or ataxia, MRI can exclude other central nervous system diseases and sometimes show subtle changes related to hereditary neuropathy. PFM Journal+2PMC+2
20. Peripheral nerve ultrasound or MR neurography (specialized tests) – in some centers, high-resolution ultrasound or MRI of peripheral nerves is used to visualize nerve size and structure, helping differentiate hereditary neuropathies from inflammatory or focal nerve problems. PFM Journal+2ARUP Consult+2
Non-pharmacological treatments
1. Physiotherapy (physical therapy)
Physiotherapy is one of the most important non-drug treatments for CMT2 due to NEFL mutation. A physiotherapist teaches safe stretching, strengthening, balance, and low-impact aerobic exercises to keep joints flexible and muscles as strong as possible. Regular sessions help slow contractures (stiff joints), reduce pain related to stiffness, and improve walking and standing balance. Exercise programs are gentle and are adapted to fatigue and weakness so that nerves and muscles are not overworked. ScienceDirect+3Physiopedia+3PMC+3
2. Occupational therapy
Occupational therapists focus on making daily life easier at home, school, or work. They assess hand weakness, fine finger control, and fatigue, then suggest adapted tools such as built-up pens, special kitchen handles, or computer devices. They also advise on energy-saving techniques, planning rest periods, and arranging the home to avoid falls. The main purpose is to keep independence and reduce physical strain during daily tasks. PMC+1
3. Ankle–foot orthoses (AFOs)
AFOs are lightweight plastic or carbon braces fitted around the ankle and foot. In CMT2, foot-drop is common because the muscles that lift the foot are weak. AFOs hold the ankle in a normal position, prevent tripping, and reduce fatigue when walking. Good braces can greatly improve stability and confidence and may delay painful deformities of the foot. An orthotist adjusts the brace as the disease and body change. Charcot-Marie-Tooth Association+2Muscular Dystrophy Association+2
4. Custom footwear and insoles
People with CMT2 often develop high-arched feet or claw toes, which put pressure on small areas and cause pain and calluses. Special shoes with extra depth, soft uppers, and wide toe boxes reduce pressure and help fit AFOs. Custom insoles spread weight more evenly across the foot. This reduces pain, helps balance, and lowers the chance of skin breakdown and ulcers. PMC+1
5. Stretching and contracture prevention
Daily gentle stretching of calf muscles, hamstrings, and foot muscles helps keep joints flexible and delays fixed deformities. A physiotherapist teaches slow, controlled stretches, often held for 20–30 seconds and repeated several times. The purpose is to prevent the muscles and tendons from shortening, which would make walking harder and more painful and could later require surgery. Physiopedia+2PMC+2
6. Balance and gait training
Because sensory loss and weakness disturb balance, many patients walk with an unsafe, unsteady gait. Balance training includes exercises like standing on different surfaces, stepping tasks, and using visual cues. Gait training may involve treadmill walking or practice with different walking aids. The goal is to build safer walking patterns, reduce falls, and increase confidence in moving on stairs or uneven ground. PMC+2ScienceDirect+2
7. Strength training with low resistance
Carefully planned strength training with low weights or elastic bands helps preserve remaining muscle strength without causing excessive fatigue. The focus is on proximal muscles (hips, shoulders, core) that support posture and compensate for distal weakness. Sessions are short and spaced out, and pain or prolonged exhaustion after exercise is a sign to reduce intensity. PMC+2Charcot-Marie-Tooth Disease+2
8. Aerobic exercise (swimming, cycling, walking)
Low-impact aerobic exercise such as swimming, cycling, and brisk walking improves heart and lung fitness and helps maintain a healthy weight. For CMT2, water-based exercise is often ideal because buoyancy supports weak limbs. Aerobic activity also improves mood and sleep and may help reduce chronic pain perception. Intensity is usually moderate and tailored to the person’s tolerance. nhs.uk+2Charcot-Marie-Tooth Disease+2
9. Podiatry and foot care
Podiatrists treat calluses, nail problems, and areas of high pressure on the feet. Because sensation is reduced, small injuries may go unnoticed and become ulcers. Regular foot checks, nail care, skin moisturising, and early treatment of corns or blisters prevent infection and serious complications. Advice on socks and shoes also reduces skin damage. Muscular Dystrophy Association+1
10. Hand therapy and splints
Hand therapists can design splints or supports for weak fingers and wrists. These devices help hold the hand in a more functional position for writing, typing, and gripping objects. Specific finger and grip exercises can also slow loss of fine motor control. The aim is to keep independence in schoolwork, phone use, and personal care for as long as possible. PMC+1
11. Walking aids (canes, crutches, walkers)
When balance and leg strength decline, a cane, crutch, or walker can greatly reduce the risk of falls. A physiotherapist chooses the right device and height and trains safe use indoors and outdoors. This does not mean “giving up”; instead, it is a tool to save energy, walk farther, and stay socially active. PMC+1
12. Wheelchairs and mobility scooters (for long distances)
Some people with NEFL-related CMT need a wheelchair or scooter, especially for long distances or rough ground. Using mobility devices early can prevent falls, injuries, and extreme fatigue. It also allows participation in school, work, or family trips that would otherwise be impossible. Many people still walk short distances at home while using a chair outside. PMC+2Muscular Dystrophy Association+2
13. Pain management with non-drug methods
Non-drug pain strategies include heat or cold packs, gentle massage, relaxation, breathing exercises, and mindfulness. These methods reduce muscle tension and help the brain handle chronic pain signals. They are safe tools that can be used together with medications and often give better control with fewer side effects when used regularly. PMC+1
14. Psychological support and counselling
Living with a lifelong, inherited disease can cause sadness, anxiety, or low self-confidence. Talking with a psychologist, counsellor, or support group helps people manage emotional stress and adjust to physical changes. Cognitive-behavioural therapy (CBT) can also help with chronic pain coping and fatigue management. Good mental health improves motivation to exercise and follow treatment plans. PMC+1
15. Genetic counselling
NEFL-related CMT is usually inherited in an autosomal dominant way, meaning each child of an affected parent has about a 50% chance of inheriting the mutation. Genetic counselling explains inheritance patterns, the meaning of genetic test results, and options for family planning. It also helps relatives decide whether they want testing and prepares them for possible outcomes. ScienceDirect+2CMT Research Foundation+2
16. School and workplace accommodations
Students and workers with CMT2 can benefit from written accommodations: extra time for tasks, permission to use elevators, ergonomic chairs, speech-to-text software, or flexible schedules. Occupational therapists and doctors can write letters explaining functional limits. The purpose is to reduce physical strain, prevent overuse injuries, and keep people active in education and employment. PMC+1
17. Home safety modifications
Simple changes at home lower the risk of falls and injuries: removing loose rugs, adding grab bars in the bathroom, improving lighting, and using non-slip mats. Placing frequently used items at reachable heights avoids climbing or bending. These changes are inexpensive but can prevent serious fractures, especially when balance is poor. Muscular Dystrophy Association+1
18. Weight management and nutrition counselling
Extra weight makes walking harder and increases stress on weak ankles and knees. A dietitian can design a balanced meal plan that supports healthy weight, adequate protein, vitamin intake, and stable energy. Good nutrition also supports immune function and tissue repair, which is important when skin or joints are under strain. PMC+1
19. Sleep hygiene measures
Pain, muscle cramps, and anxiety can disturb sleep in CMT. Regular sleep schedules, avoiding caffeine late in the day, relaxing routines, and comfortable positioning with pillows or splints help improve sleep quality. Better sleep reduces daytime fatigue and may improve pain tolerance and mood. PMC+1
20. Patient education and support groups
Learning about NEFL-related CMT2 helps people understand what to expect and how to protect their health. Support organizations for CMT provide information, webinars, and peer support. Sharing experiences with others facing similar challenges reduces isolation and can offer practical tips for daily living, devices, and services. Muscular Dystrophy Association+2CMT Research Foundation+2
Drug treatments
Important: No medicine currently cures CMT2 caused by NEFL mutation. Drugs are used mainly to treat symptoms such as neuropathic pain, muscle spasms, mood problems, or sleep issues. All doses must be chosen by a doctor; never start or change medicines on your own, especially as a teen.
1. Gabapentin
Gabapentin is an anti-seizure drug widely used to treat neuropathic pain. It reduces abnormal firing of nerve cells by acting on calcium channels. FDA-approved uses include post-herpetic neuralgia and seizures, but doctors often use it “off-label” for CMT-related nerve pain. Typical adult doses range from 900–3600 mg per day, divided into three doses, but lower doses are used first and adjusted slowly. Common side effects are sleepiness, dizziness, and swelling. FDA Access Data+2FDA Access Data+2
2. Pregabalin (Lyrica / Lyrica CR)
Pregabalin is similar to gabapentin and is approved for several types of neuropathic pain in adults, including diabetic neuropathy and post-herpetic neuralgia. It binds to the same type of calcium channel and reduces the release of pain-related neurotransmitters. Usual adult doses are 150–300 mg/day in divided doses, increased cautiously. Side effects include dizziness, weight gain, and blurred vision. It may be used off-label for painful CMT2. FDA Access Data+2FDA Access Data+2
3. Duloxetine (Cymbalta)
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant approved for diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. It increases levels of serotonin and norepinephrine in pain pathways and can ease burning or shooting sensations. Typical adult doses are 30–60 mg once daily. It can cause nausea, dry mouth, sweating, and rarely liver problems or mood changes. In CMT, it may be used off-label for neuropathic pain and co-existing depression or anxiety. FDA Access Data+1
4. Amitriptyline
Amitriptyline is a tricyclic antidepressant that has long been used in low doses for nerve pain. It blocks reuptake of serotonin and norepinephrine and may also block certain pain receptors. Bedtime doses of 10–75 mg are common for adults, but doctors start very low. Side effects include dry mouth, constipation, weight gain, and drowsiness, and it must be used cautiously in heart disease and in young people due to mood effects. ScienceDirect+1
5. Nortriptyline
Nortriptyline is another tricyclic antidepressant with fewer sedating and anticholinergic effects than amitriptyline for some people. It is also used off-label for neuropathic pain. Doses often start at 10–25 mg at night and increase slowly. Side effects are similar—dry mouth, constipation, dizziness—and heart rhythm monitoring may be needed in some patients. It can be helpful when gabapentin or duloxetine alone is not enough. ScienceDirect+1
6. Tramadol
Tramadol is a synthetic opioid analgesic with extra serotonin/norepinephrine reuptake inhibition, used for moderate to moderately severe pain. It is not a first-line drug in CMT because of dependence and side-effect risks, but short courses may be used when other treatments fail. Usual adult doses are 50–100 mg every 4–6 hours as needed, with a maximum daily limit; extended-release forms exist for chronic pain. Common side effects include nausea, dizziness, constipation, and serious risks include dependence, breathing suppression, and seizures. FDA Access Data+2FDA Access Data+2
7. NSAIDs (ibuprofen, naproxen, etc.)
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen help with inflammatory or musculoskeletal pain, for example from joint strain caused by abnormal gait. They do not treat nerve damage itself but may ease mild to moderate pain. Doses and timing must follow label instructions, especially in teens, to avoid stomach, kidney, or bleeding problems. They should not be used long term without medical supervision. ScienceDirect+1
8. Baclofen
Baclofen is a muscle relaxant that targets GABA-B receptors in the spinal cord and is used to treat spasticity from conditions such as multiple sclerosis or spinal cord disease. In some CMT patients with increased muscle tone, low doses may help reduce stiffness and spasms. Adult oral doses can be titrated up to around 80 mg/day in divided doses under specialist care. Side effects include drowsiness, weakness, and dizziness. FDA Access Data+2FDA Access Data+2
9. Tizanidine
Tizanidine is another muscle relaxant that acts on alpha-2 adrenergic receptors to reduce spasticity. It can ease muscle tightness and painful spasms, but may cause low blood pressure, dry mouth, and drowsiness. Dosing is individualized and increased slowly. It is usually reserved for people with significant spasticity that limits movement or sleep. ScienceDirect
10. Topical lidocaine patches
Lidocaine 5% patches deliver a local anaesthetic directly through the skin over painful areas, such as the feet. They are approved for post-herpetic neuralgia, but also used off-label in other neuropathic pain. The patch is usually applied for up to 12 hours in 24 hours. Side effects are mainly local skin irritation. This option avoids whole-body side effects of oral pain medicines. ScienceDirect
11. Capsaicin cream or patches
Capsaicin from chili peppers reduces pain by depleting substance P from nerve endings. Low-strength creams can be applied several times a day, while high-dose patches are applied in clinics for longer relief. Burning or stinging at first is common. In CMT, capsaicin may lessen localized burning pain in the feet or hands. ScienceDirect
12. Low-dose opioids (specialist use)
In severe cases of chronic pain not relieved by other methods, a pain specialist may prescribe low-dose opioid medicines. Because of dependence, tolerance, overdose risk, and constipation, they are used with great caution and are generally avoided in young people when possible. They do not treat nerve damage and are usually reserved for short-term relief or palliative settings. FDA Access Data+1
13. Sleep medicines (short-term)
If severe pain, cramps, or anxiety disturb sleep, doctors may use short courses of sleep medicines such as melatonin or certain sedating antidepressants at bedtime. The goal is to break a vicious cycle of pain and insomnia. These drugs must be used for limited periods and under close supervision to avoid dependence and daytime drowsiness. ScienceDirect
14. Anti-cramp medicines (e.g., mexiletine – specialist)
Some neuromuscular specialists use drugs like mexiletine (a sodium-channel blocker used for heart rhythm problems) to treat severe muscle cramps. Evidence is limited, and the drug can affect heart rhythm, so careful monitoring is needed. It is considered only when cramps are very disabling and other options have failed. ScienceDirect
15. Vitamin D supplementation (medicinal doses)
When blood tests show vitamin D deficiency, doctors may prescribe higher-dose vitamin D as a medicinal product to support bone health and reduce fracture risk, especially in people with reduced mobility. Doses and schedules depend on age, baseline levels, and kidney function. Too much vitamin D can cause high calcium and kidney damage, so blood levels must be monitored. ScienceDirect
16. Antidepressants for mood and pain modulation
Beyond duloxetine and tricyclics, other antidepressants may be used to manage depression and anxiety related to chronic disease. Treating mood symptoms often reduces perceived pain and improves adherence to physical therapy. Drug choice and dosage must be carefully selected in teens, with close mental-health follow-up. ScienceDirect+1
17. Anti-anxiety medicines (short-term)
In some situations, short-term anti-anxiety medications may be used for panic attacks or strong anxiety linked to chronic illness or procedures. Because of dependence and sedation risk, they are not a long-term solution. Psychotherapy and coping strategies remain more important for lasting benefits. ScienceDirect
18. Constipation treatments linked to pain medicines
Many pain medicines, especially opioids and tricyclics, can cause constipation. Stool softeners, fiber supplements, and laxatives may be required to keep bowel movements regular. This reduces abdominal pain and increases comfort, especially when activity is limited. All bowel medicines should be chosen with a doctor or pharmacist. ScienceDirect
19. Anti-nausea medicines
Some neuropathic pain and antidepressant drugs cause nausea or vomiting. Short-term anti-nausea medicines can make it easier to continue important treatments. The choice depends on age, other medicines, and heart rhythm risk. Side effects such as drowsiness or constipation should be watched carefully. ScienceDirect
20. Clinical-trial medications
Several experimental drugs and gene-targeted therapies are under study for CMT, especially other subtypes like CMT1A. For NEFL-related CMT2, research is exploring approaches that modify neurofilament function or improve axonal health, but no specific drug is yet approved. Participation in a registered clinical trial is the safest way to access such treatments. ScienceDirect+2PLOS+2
Dietary molecular supplements
Always discuss supplements with your doctor or a dietitian, because high doses or mixing with medicines can be harmful.
1. Vitamin B12 (cobalamin)
Vitamin B12 is essential for healthy myelin, the insulation around nerves. Low B12 can cause or worsen neuropathy. Supplements in doses like 250–1000 mcg/day are often used when deficiency is present. The purpose is to correct low levels and support nerve repair. It works by helping produce DNA and maintaining myelin structure.
2. Vitamin B1 (thiamine) and B6 (pyridoxine)
Thiamine and pyridoxine are also important for nerve energy metabolism and neurotransmitter production. In people with poor diet or certain medical conditions, these vitamins may be low. Moderate supplement doses can support nerve function, but very high B6 doses over long periods can actually damage nerves, so medical supervision is important.
3. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. It helps reduce oxidative stress in nerves and may improve burning pain or numbness. Typical supplemental doses are around 300–600 mg/day in adults in studies, but the exact benefit in CMT is not fully proven. It can cause stomach upset and should be avoided in some thyroid or diabetes conditions.
4. Acetyl-L-carnitine
Acetyl-L-carnitine helps transport fatty acids into mitochondria to make energy. Some small studies suggest it may support nerve regeneration and reduce pain in peripheral neuropathy. Doses used in research often range from 500–2000 mg/day. It may cause mild nausea or restlessness and should be used under medical guidance, especially if there are heart or kidney problems.
5. Omega-3 fatty acids (EPA/DHA)
Omega-3 fats from fish oil or algae support cell membranes and may have anti-inflammatory effects. They can benefit heart health and might indirectly support nerve health and mood. Typical supplemental doses range from 500–2000 mg/day of combined EPA/DHA. They can increase bleeding risk at higher doses, especially when used with anticoagulant medicines.
6. Coenzyme Q10 (CoQ10)
CoQ10 is a mitochondrial cofactor that helps cells generate energy and acts as an antioxidant. Some patients with neuromuscular disorders use it to combat fatigue, though evidence is mixed. Doses commonly range from 100–300 mg/day. Side effects are usually mild, such as stomach upset, but CoQ10 can interact with blood-thinning medicines.
7. Vitamin D (nutritional supplement)
Low vitamin D is common in people with limited outdoor activity. Correcting deficiency with daily or weekly doses supports bone health and muscle function and may reduce fracture risk if falls occur. Dose depends on blood tests and age. Excess vitamin D can raise calcium and damage kidneys, so levels should be monitored.
8. Magnesium
Magnesium is involved in muscle relaxation and nerve signaling. Mild deficiency can cause cramps or muscle twitching. Supplements in modest doses may help some people with cramps, though evidence is limited. High doses can cause diarrhea and problems in kidney disease, so blood levels and kidney function must be considered.
9. Curcumin (from turmeric)
Curcumin has anti-inflammatory and antioxidant properties in laboratory studies. Some people use it hoping to reduce inflammation and pain. It is poorly absorbed on its own, so many products combine it with piperine or special formulations. High doses can upset the stomach and may interact with blood-thinning drugs. Evidence in CMT is still experimental.
10. Multivitamin and mineral complexes
When diet is unbalanced, a low-dose multivitamin can help cover basic needs without high pharmacological doses of any single nutrient. It supports general health, immunity, and tissue repair but is not a treatment for NEFL-related CMT itself. It should not replace a healthy diet rich in fruits, vegetables, whole grains, and lean proteins.
Immunity-booster, regenerative, and stem-cell-related drugs
There are no FDA-approved immune-booster or stem-cell drugs specifically for CMT2 caused by NEFL mutation. The options below are general or experimental concepts discussed in neuromuscular medicine. They must only be considered in research settings or under specialist care. ScienceDirect+2PLOS+2
1. Intravenous immunoglobulin (IVIG) – for other immune neuropathies
IVIG is a blood product used to treat autoimmune neuropathies such as CIDP. It provides pooled antibodies that modulate the immune system. It is not standard for genetic CMT2 but may be used if there is diagnostic doubt or overlapping immune disease. Dosing and infusion schedules are strictly controlled in hospital, and side effects include headache, clots, and kidney injury.
2. Hematopoietic stem-cell transplantation (HSCT) – research context
HSCT replaces the blood-forming system and is used for some immune and metabolic disorders. For purely genetic CMT2E due to NEFL, HSCT is not established treatment. In theory, modified stem cells might one day carry corrected genes, but this remains experimental. HSCT carries major risks, including infection, graft-versus-host disease, and death, so it is only done for severe, proven indications.
3. Gene-therapy vectors (experimental)
Researchers are exploring viral vectors (such as AAV) to deliver healthy copies of genes or silence harmful ones in inherited neuropathies. For NEFL-related CMT, lab studies and animal models are in early stages. No gene therapy for CMT2E is currently approved. Clinical trials, when available, will define safe doses, delivery routes, and long-term effects. ScienceDirect+2PLOS+2
4. Neurotrophic factor–based drugs (experimental)
Some experimental drugs aim to mimic or boost natural nerve growth factors to support axon survival and regeneration. They might protect nerves from degeneration in conditions like CMT. However, delivering these factors in safe, targeted ways is challenging, and studies so far have not produced approved medicines for CMT. Participation in clinical trials is the correct pathway for access. ScienceDirect
5. Mitochondria-targeted antioxidants
Certain research drugs act directly on mitochondria to reduce oxidative stress and improve energy production in nerve cells. Early studies in other neuromuscular diseases suggest possible benefits but also highlight safety and dosing questions. These medicines are not standard care for NEFL-related CMT and should only be used in regulated trials. ScienceDirect+1
6. Experimental small-molecule modifiers of neurofilament function
Because NEFL mutations directly affect neurofilament proteins, researchers are considering small molecules that might correct misfolding or aggregation. These are at very early research stages in cells or animals. No dosing schedule for humans is defined, and none are approved. At present, information is mainly relevant for future therapies and scientific understanding. ScienceDirect+2Wiley Online Library+2
Surgeries
1. Foot deformity correction (osteotomies and tendon transfers)
CMT2 often leads to high-arched (cavus) feet and clawed toes that cause pain, instability, and skin breakdown. Orthopaedic surgeons can realign bones (osteotomies) and move tendons to balance muscle forces. The aim is to place the foot in a more neutral position, improve weight bearing, and make it easier to use braces and shoes. Muscular Dystrophy Association+1
2. Achilles tendon lengthening
Tight calf muscles and Achilles tendons can pull the heel up and make it impossible to place the heel on the ground. Surgical lengthening of the tendon can restore a more normal ankle angle and improve walking. It is usually done when stretching and braces are no longer enough and is combined with physiotherapy afterward. Muscular Dystrophy Association+1
3. Toe deformity surgery (claw-toe corrections)
Clawed toes can rub in shoes, causing painful calluses and ulcers. Surgeons may straighten the toes by releasing tight tendons or fusing small joints. This reduces pain, improves shoe fit, and lowers infection risk. Sometimes these procedures are combined with other foot surgeries to correct overall alignment. Muscular Dystrophy Association+1
4. Joint fusion (arthrodesis) for severe instability
In very unstable ankles or midfoot joints that have failed brace treatment, fusion surgery may be offered. The surgeon permanently joins bones so the joint no longer moves but becomes more stable. While flexibility is lost, pain and wobbling may improve, making standing and walking safer with AFOs or supportive shoes. Muscular Dystrophy Association+1
5. Spine or hand surgeries (rare, case-by-case)
Some patients develop severe scoliosis or hand deformities that interfere with breathing or hand use. In such cases, spinal fusion or hand tendon surgeries may be considered. Decisions are highly individualized and involve detailed discussions about risks, recovery time, and realistic benefits. Orthopaedic and neuromuscular specialists work together to select the best timing. PMC+1
Prevention strategies
Avoid nerve-toxic medicines – Some chemotherapy and other drugs can damage peripheral nerves. People with NEFL-related CMT should remind every doctor about their neuropathy so safer alternatives can be chosen when possible. ScienceDirect
Protect feet and skin – Daily foot checks, good shoes, and prompt care of blisters or cuts prevent ulcers and serious infections, especially when sensation is reduced. Muscular Dystrophy Association
Prevent falls – Use braces, walking aids, and home safety changes to reduce fall risk. Early use of supports is prevention, not failure. PMC+1
Stay physically active within limits – Regular, gentle exercise prevents deconditioning and contractures. Over-exertion that causes long-lasting pain or weakness should be avoided. PMC+1
Maintain healthy weight – Keeping weight in a normal range reduces stress on weak joints and makes walking and transfers easier. ScienceDirect
Vaccinations – Staying up to date with routine vaccines helps prevent infections, which can worsen weakness and lead to hospitalisation. ScienceDirect
Early orthopaedic and rehabilitation reviews – Regular checks by physiatrists and orthopaedic surgeons can detect deformities early, when braces or minor procedures may be enough. PMC+2Muscular Dystrophy Association+2
Good mental-health care – Treating anxiety and depression early helps people stay engaged with exercise and school or work, indirectly preventing health decline. PMC+1
Family genetic counselling – Knowing the genetic status of at-risk relatives helps them plan life decisions and watch for early symptoms, which can lead to earlier supportive care. ScienceDirect+2CMT Research Foundation+2
Regular specialist follow-up – Lifelong review by a neuromuscular team allows timely adjustments in braces, therapies, and medications as the condition slowly changes. PMC+1
When to see doctors
You should see a doctor (preferably a neurologist familiar with neuromuscular disease) if you notice slowly progressive weakness in the feet or hands, frequent tripping, high-arched feet, or family history of CMT. Early assessment with nerve conduction studies and genetic tests can confirm the diagnosis and start supportive care sooner. Muscular Dystrophy Association+2CMT Research Foundation+2
If you already have NEFL-related CMT2, see your doctor urgently if you have sudden worsening of weakness, new severe pain, repeated falls, skin ulcers that do not heal, fever with leg redness, or breathing or swallowing difficulties. You should also seek help for new depression, anxiety, or thoughts of harming yourself, especially after starting or changing neurological or pain medicines, because some drugs can increase these risks. FDA Access Data+3FDA Access Data+3FDA Access Data+3
What to eat and what to avoid
Focus on a balanced diet – Eat plenty of vegetables, fruits, whole grains, lean proteins, and healthy fats to support overall health, weight control, and tissue repair.
Include good protein sources – Fish, poultry, eggs, dairy, beans, and lentils give amino acids needed for muscle maintenance and immune function.
Choose healthy fats – Use olive oil, nuts, seeds, and fatty fish for omega-3s, which support heart health and may reduce inflammation.
Stay well hydrated – Adequate fluids help prevent constipation, especially when taking pain medicines that slow the gut.
Limit sugary drinks and sweets – High sugar intake can lead to weight gain and blood-sugar swings, which may worsen fatigue and, in diabetes, nerve damage.
Avoid heavy alcohol use – Alcohol is directly toxic to peripheral nerves and can worsen neuropathy; many medicines also interact with alcohol.
Limit very high-dose single supplements without supervision – Excessive vitamin B6, vitamin D, or others can harm nerves or organs; always check doses with a doctor.
Reduce highly processed, salty, and fried foods – These foods contribute to weight gain and cardiovascular risk, which can limit mobility further.
Be cautious with herbal products promising “nerve cure” – Many have no scientific proof, may be contaminated, or interact with prescription medicines.
Work with a dietitian if eating is difficult – If fatigue, depression, or financial issues make it hard to eat well, a dietitian or social worker can help plan affordable, simple meals.
Frequently asked questions
1. Is NEFL-related Charcot-Marie-Tooth disease type 2 curable?
At present, NEFL-related CMT2 is not curable. The genetic change in the NEFL gene is present in every cell from birth. Current treatments focus on symptom control, maintaining mobility, preventing complications, and supporting emotional well-being. Research into gene-based and regenerative therapies is ongoing but still experimental. ScienceDirect+2Wiley Online Library+2
2. How fast does this disease usually progress?
Progression is generally slow over many years. Many people notice problems in childhood or early adult life that very gradually worsen. Some individuals remain able to walk with braces for decades, while others need wheelchairs for longer distances. The exact course varies even within the same family and depends on the specific NEFL mutation and other factors. ScienceDirect+2PLOS+2
3. Can exercise make the disease worse?
Appropriate, low-to-moderate-intensity exercise does not usually make CMT worse and is recommended to keep muscles and joints healthy. Very heavy exercise that causes prolonged pain or extreme tiredness should be avoided. Working with a physiotherapist helps find the right balance between activity and rest. ScienceDirect+3Physiopedia+3PMC+3
4. Is it safe to play sports?
Some non-contact sports and activities such as swimming, cycling, or walking are often safe and helpful. High-impact or contact sports that increase fall and injury risks may not be suitable, especially if balance is poor. A doctor and physiotherapist can advise which sports are safest for each individual. PMC+2Charcot-Marie-Tooth Disease+2
5. Could I pass this disease to my children?
NEFL-related CMT2 is often autosomal dominant, so each child of an affected person has about a 50% chance of inheriting the mutated gene. Genetic counselling can explain options such as partner testing, prenatal testing, or assisted-reproduction techniques for those who wish to consider them in adulthood. ScienceDirect+2CMT Research Foundation+2
6. What tests confirm NEFL-related CMT2?
Doctors usually perform a neurological exam, nerve conduction studies, and sometimes electromyography to show axonal neuropathy. Genetic testing panels that include NEFL can then confirm the exact mutation. In the past, nerve biopsies were sometimes used, but today they are needed less often because genetic tests are more available. ScienceDirect+2Wiley Online Library+2
7. Why are pain medicines from accessdata.fda.gov labels used “off-label”?
FDA labels, available on accessdata.fda.gov, describe approved uses such as diabetic neuropathy or post-herpetic neuralgia for drugs like gabapentin, pregabalin, and duloxetine. Doctors sometimes use these same medicines for CMT-related neuropathic pain even though CMT is not specifically named on the label. This is called off-label use and is common when diseases are rare and trials are limited. FDA Access Data+3FDA Access Data+3FDA Access Data+3
8. Are there special risks from these pain medicines in young people?
Yes. Medicines such as gabapentin, pregabalin, duloxetine, tricyclic antidepressants, and opioids can cause mood changes, dizziness, falls, and dependence. Some increase the risk of suicidal thoughts. For teens, doctors use the lowest effective doses, monitor closely, and combine medicines with non-drug pain strategies. Family members should watch for sudden mood or behaviour changes. FDA Access Data+3FDA Access Data+3FDA Access Data+3
9. Will I end up in a wheelchair?
Not everyone with NEFL-related CMT2 needs a wheelchair, and if they do, it may be mainly for long distances. The goal of treatment is to delay or minimise mobility loss using physiotherapy, orthoses, and early orthopaedic care. Using a wheelchair is not a failure; it is a tool that can extend independence and participation in life. PMC+2Muscular Dystrophy Association+2
10. Can surgery fix my neuropathy?
Surgery can correct bone and tendon deformities caused by muscle imbalance, but it cannot repair damaged nerves or change the underlying genetic cause. It is helpful when deformities cause pain, ulcers, or major walking problems despite braces and therapy. Decisions require careful examination and consultation with experienced surgeons. Muscular Dystrophy Association+1
11. What is the difference between CMT1 and CMT2 in this context?
CMT1 mainly affects the myelin sheath (demyelinating neuropathy), while CMT2 primarily affects the axon, the core of the nerve fiber (axonal neuropathy). NEFL mutations can cause both patterns (CMT1F and CMT2E), but in CMT2 the nerve conduction velocities are often near-normal or only mildly slowed, with reduced response amplitudes. Muscular Dystrophy Association+2Wiley Online Library+2
12. Can I have anaesthesia or surgery safely?
Most people with CMT can have anaesthesia safely, but the anaesthetist must be told about the neuropathy. Certain muscle-relaxant drugs and positioning issues may need special care. Pre-operative assessment considers breathing, scoliosis, and any heart problems. A written summary from the neurologist is useful before planned surgery. ScienceDirect
13. Does CMT2 affect the brain or thinking?
NEFL-related CMT2 mainly affects peripheral nerves. Most people have normal intelligence and thinking. In rare cases with very early onset or associated conditions, there may be more widespread nervous-system involvement, but this is unusual. If learning or behaviour changes occur, they should be assessed separately. ScienceDirect+2Wiley Online Library+2
14. Are there lifestyle changes that really make a difference?
Yes. Keeping active, maintaining healthy weight, avoiding smoking and heavy alcohol, protecting feet, and attending regular check-ups all make a real difference over years. These habits cannot change the gene, but they can strongly influence comfort, independence, and complication risk. ScienceDirect+3PMC+3nhs.uk+3
15. Where can I find reliable information and support?
Reliable sources include national health services, neuromuscular organisations, and CMT-specific foundations, which provide evidence-based information and updates on research and clinical trials. Examples are patient guides from major neuromuscular associations and dedicated CMT organisations. They also host support groups and educational materials for patients and families. Muscular Dystrophy Association+2CMT Research Foundation+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 29, 2025.
